Board of Directors to approve the half-year financial report as of June 30th 2022 subject to voluntary and limited audit.
Categories
Farmacosmo InvestorsFarmacosmo InvestorsBoard of Directors to approve the half-year financial report as of June 30th 2022 subject to voluntary and limited audit.